Navigation Links
Type of inhaler used in asthma treatment crucial

Asthma is one of the most prevalent diseases in our society with more than five million people being affected with the disease, in the UK alone. According to a major study in the UK, in which researchers examined the medical records of almost 900,000 asthma patients across the UK, asthma sufferers are dying needlessly because they are not being prescribed the most suitable inhalers. The study compared levels of asthma control and the need and number of doctor appointments for// patients using the different devices. The scientists found that sufferers had far better control of their condition using inhalers they could activate by breathing in, compared with the traditional "press and breathe" devices more commonly prescribed by doctors.

Professor David Price, who led the study, said that there are a wide variety of inhaler devices available for the delivery of medication into the lungs and using the correct inhaler was crucial. He added that outcomes were consistently better in those using the breath-actuated device, with less use of rescue medication for asthma symptoms, fewer courses of steroids and less courses of antibiotics for respiratory infections prescribed to this group.


'"/>




Page: 1

Related medicine news :

1. Drug In Asthma inhaler Found To Counteract Benefits
2. Study disapproves a new Asthma inhaler
3. Fireworks can spell death for asthmatic children
4. New vaccine helps allergy and asthma patients
5. New vaccine helps allergy and asthma patients
6. Nearly all asthma deaths preventable
7. Soluble IL-4 Receptor - A new boon for asthmatics
8. Cats to protect children from asthma
9. Dampness related to asthma
10. Safe for people with asthma
11. Reduced POD linked to fatal asthma attacks
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... NC (PRWEB) , ... December 08, 2016 , ... ... Medicare and the Affordable Care Act. Dr. Botelho advocates for the mass media ... story movement gives people ongoing opportunities to share their unfortunate experiences; such a ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... that serve communities in and around the greater Phoenix metropolitan region, is announcing ... Connection. , The mission of the Homeless Youth Connection is to promote community ...
(Date:12/7/2016)... ... December 07, 2016 , ... DrugDev again demonstrated its dedication ... one of the early adopters completing EU-U.S. Privacy Shield Certification from the U.S. Department ... on both sides of the Atlantic with a mechanism to comply with EU data ...
(Date:12/7/2016)... Orleans, LA (PRWEB) , ... December 07, 2016 ... ... technique used to treat wrinkles and deep lines by smoothing and tightening the ... minimally invasive techniques out there to address facial aging with very little downtime, ...
(Date:12/7/2016)... ... 07, 2016 , ... It is vital for any lab to secure funding, ... The team at Beckman Coulter has designed Kaluza, templates with advanced analytical tools to ... to operate in a GLP (Good Laboratory Practice) fashion. , With features designed to ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... Dec 8, 2016 Research and Markets has announced ... report to their offering. ... , The report provides separate comprehensive ... , and Rest of World. Annual estimates and ... historic analysis is provided for these markets. Market data and analytics are ...
(Date:12/7/2016)... Dec. 7, 2016 "Lantus (Insulin Glargine) Biosimilar Clinical Trial & ... biosimilar version of Lantus drug in clinical pipeline. Currently 5 biosimilar version ... Japan , Kenya , Czech ... , China , Slovakia , ... 2 diabetes mellitus. The patent on Lantus expired in 2014. Lantus ...
Breaking Medicine Technology: